Hélène Nègre

Helene NEGRE, PharmD, PhD, developed her expertise in Cell & Gene Therapy CMC through more than 20 years of experience in Advanced Therapy Medicinal Product (ATMPs). Initially, she worked at Pitié-Salpêtrière Hospital (AP-HP) in the Biotherapy department (Pr. Klatzmann). In 2014, she joined Dana Farber Cancer Institute (Boston) and worked for 5 years as technical Director of the Novel Cell therapy team in the Cell Manipulation Core Facility (Pr. Ritz). Since 2019, she works at Servier and is now Scientific Director - Biotechnology and Bioproduction and the EFPIA project leader for the IMI program T2Evolve on engineered T cells.